Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yawei Zheng"'
Publikováno v:
Stem Cells Translational Medicine, Vol 10, Iss S2, Pp S75-S84 (2021)
Stem Cells Translational Medicine
Stem Cells Translational Medicine
Autologous hematopoietic stem cell transplantation (ASCT) remains an important postremission treatment for acute leukemia (AL). It is known that some prognostic factors, such as age, cytogenetic and molecular risk stratification, and minimal residual
Autor:
Sizhou Feng, Yaojin Huang, Yapu Li, Yunhong Tian, Xiuxiu Yin, Fang Dong, Yongxin Ru, Mei Wang, Xiaowei Xie, Shangda Yang, Shihui Ma, Sha Hao, Linping Hu, Hui Cheng, Biao Zhang, Aiming Pang, Caiying Zhu, Yawen Zhang, Shulian Chen, Yawei Zheng, Wenbin Cao, Erlie Jiang, Tao Cheng
Publikováno v:
Blood
Total body irradiation (TBI) is commonly used in host conditioning regimens for human hematopoietic stem cell (HSC) transplantation to treat various hematological disorders. Exposure to TBI not only induces acute myelosuppression and immunosuppressio
Autor:
Weiping Yuan, Chunlan Hua, Tao Cheng, Feng Chun Yang, Sha Hao, Yawei Zheng, S Ma, Hui Shi, Xin Gu, M Lim, Yakun Pang
Publikováno v:
Leukemia. 30(1)
Degeneration of normal hematopoietic cells is a shared feature of malignant diseases in the hematopoietic system. Previous studies have shown the exhaustion of hematopoietic progenitor cells (HPCs) in leukemic marrow, whereas hematopoietic stem cells
Autor:
Yawei Zheng, Heping Cheng, Yanning Liu, Weiping Yuan, Jian Xu, Hongli Zhang, Tongbiao Zhao, Tao Cheng, Sha Hao, Yulian Wang, Kaihui Liu
Publikováno v:
Blood Cancer Journal
Somatic cells can be reprogrammed into induced pluripotent stem (iPS) cells using the reprogramming factors (Oct4, Sox2, Klf4 and c-Myc, also called OSKM).1 Cellular reprogramming and oncogenesis share many common features. The application of the iPS
Publikováno v:
Blood. 126:3634-3634
Acute myeloid leukemia (AML) is a heterogeneous hematopoietic disorder with poor prognosis. DNA methylation may play a vital role in the development of AML. Dnmt3a and Dnmt3b are de novo methyltransferases. Dnmt3a is frequently mutated in hematologic
Autor:
Meikuang Lim, Weiping Yuan, Shihui Ma, Tao Cheng, Hui Shi, Chunlan Hua, Yawei Zheng, Yakun Pang, Feng Chun Yang, Sha Hao
Publikováno v:
Experimental Hematology. 43:S88
Publikováno v:
Blood. 122:1214-1214
Mesenchymal stem cells (MSCs) have been shown to be able to form a niche that maintains hematopoietic stem cells (HSCs). However, how the phonotypical characteristics and biological functions of MSCs are affected and especially whether their supporti